CBD Before Surgery: What You Need to Tell Your Surgeon | PureCraft CBD

⚠ Important | Always disclose CBD use to your surgeon, anesthesiologist, and any other members of your surgical team before any procedure. This is a safety-critical disclosure. Follow your surgical team's specific guidance on when to stop CBD before your procedure — do not rely solely on this guide for surgical timing decisions. PureCraft CBD products are broad-spectrum zero-THC, batch-verified at purecraftcbd.com/pages/faq.

By the PureCraft CBD Editorial Team  |  Updated 2026  |  11 min read

The Question That Gets Asked Too Late

Most people think to mention their prescription medications to their surgeon. Many forget supplements entirely. And CBD — which occupies a mental category somewhere between food and medicine — is often not mentioned at all, particularly by people who use it regularly and consider it part of their daily routine rather than a "medication."

That is a problem. CBD has documented pharmacological effects relevant to surgery — CYP3A4 inhibition that affects anesthesia drug metabolism, mild antiplatelet activity, and direct cardiovascular and CNS effects that interact with the perioperative environment. None of these make CBD categorically contraindicated before surgery — but they all require informed surgical team awareness to manage safely.

This guide covers what surgeons and anesthesiologists need to know, what the actual risks are (clearly distinguished from overstated ones), and how to have the conversation with your surgical team.

The Pharmacological Interactions: What Actually Matters

CYP3A4 and Anesthesia Drug Metabolism

The most clinically significant CBD-surgery interaction is CYP3A4 inhibition and its effect on anesthetic drug metabolism. The majority of agents used in general anesthesia are CYP3A4 substrates — including propofol (minor CYP3A4), midazolam (CYP3A4 primary — the most common preoperative benzodiazepine), fentanyl (CYP3A4), sufentanil (CYP3A4), alfentanil (CYP3A4), and many volatile anesthetics. CBD's CYP3A4 inhibition can reduce the clearance of these agents, prolonging their effect and potentially deepening anesthesia or sedation beyond intended levels.

The clinical significance depends on CBD dose and timing. At typical supplement doses (15–25mg/day), CBD's CYP3A4 inhibition is moderate — likely producing modest rather than dramatic changes in anesthetic drug levels. However, the narrow therapeutic window of anesthesia — where the difference between adequate sedation and respiratory depression can be a small change in plasma levels — makes even modest CYP3A4 inhibition clinically relevant. The anesthesiologist's ability to titrate anesthetic agents precisely depends on predictable pharmacokinetics; CYP3A4 inhibition from recent CBD use introduces unpredictability into that titration.

The practical implication: stopping CBD sufficiently before surgery allows CYP3A4 activity to normalize, restoring predictable anesthetic pharmacokinetics. CBD's CYP3A4 inhibition is reversible — stopping CBD eliminates the inhibition; the question is how many days are required.

Antiplatelet Effects and Surgical Bleeding

CBD has documented mild antiplatelet activity — reducing platelet aggregation through CB1 receptor modulation and endocannabinoid-mediated platelet signaling pathways. This antiplatelet effect is considerably weaker than aspirin's irreversible COX-1 inhibition or prescription anticoagulants — CBD's antiplatelet mechanism is reversible with drug clearance, unlike aspirin. At supplement doses, the antiplatelet effect is modest and would not be expected to cause significant surgical bleeding in healthy patients with normal coagulation.

However, in combination with other factors that increase bleeding risk — anticoagulant medications (warfarin, DOACs), antiplatelet medications (aspirin, clopidogrel), procedures with high bleeding risk (vascular surgery, neurosurgery, major abdominal surgery) — CBD's additive antiplatelet contribution becomes more clinically relevant. For most elective surgeries in patients not on anticoagulants, the bleeding risk from CBD at supplement doses is low. Disclosure allows the surgical team to make an informed assessment based on individual procedure and patient risk factors.

Cardiovascular and CNS Effects

CBD produces direct cardiovascular effects — vasodilation, modest blood pressure reduction — that interact with the hemodynamic management of anesthesia. Anesthesia itself produces significant hemodynamic changes; CBD's vasodilatory contribution adds an additional variable that anesthesiologists should be aware of. In patients with borderline blood pressure or cardiovascular compromise, this interaction is more clinically significant than in healthy patients.

CBD's CNS depressant effects — mild compared to benzodiazepines but real — are additive to anesthetic CNS depression. This adds to the CYP3A4 concern (slower metabolism of CNS depressant anesthetic agents on top of CBD's own CNS effects) and may extend the recovery window from anesthesia. This is generally manageable but is relevant information for the anesthesiologist.

When to Stop CBD Before Surgery

The Recommended Timing Window

Current anesthesiology guidance — based on CBD's pharmacokinetics and CYP enzyme recovery — generally recommends stopping CBD at least 1–2 weeks before elective surgery. The reasoning:

CBD has a relatively long tissue half-life — while plasma half-life after oral dosing is 18–32 hours for single doses, CBD accumulates in fatty tissue with chronic daily use, producing a sustained tissue reservoir that maintains CYP3A4 inhibition beyond the plasma half-life. Stopping CBD 1–2 weeks before surgery provides sufficient time for tissue stores to clear and CYP3A4 activity to normalize in chronic daily users.

For occasional users or those who have used CBD for less than a few weeks, a shorter clearance window (5–7 days) may be sufficient — but 1–2 weeks is the conservative standard that most anesthesiologists would support.

For emergency surgery where stopping CBD is not possible, disclosure to the anesthesiologist allows them to adjust anesthetic dosing and monitoring protocols accordingly — the information is always more valuable than non-disclosure.

Procedure-Specific Risk Calibration

Not all procedures carry equal CBD interaction risk. Calibrating the urgency of cessation timing based on procedure type:

• High-risk procedures: Major surgery under general anesthesia with significant blood loss risk (vascular, cardiac, thoracic, major abdominal, neurosurgery) — 2 weeks cessation minimum; disclose explicitly to both surgeon and anesthesiologist.
• Moderate-risk procedures: Elective surgery under general anesthesia with standard blood loss risk (orthopedic, GYN, laparoscopic abdominal) — 1–2 weeks cessation; disclose to surgical team.
• Lower-risk procedures: Procedures under local or regional anesthesia without significant bleeding risk (minor dermatological, dental with local anesthetic, colonoscopy with conscious sedation) — 5–7 days cessation reasonable; disclose to proceduralist.
• Emergency surgery: Stop CBD immediately and disclose to the surgical and anesthesia team at the earliest opportunity — timing is out of the patient's control, but disclosure is still critical for anesthetic management.

The most important surgical CBD action is disclosure — to the surgeon, the anesthesiologist, and the pre-operative nursing team. Stopping CBD 1–2 weeks before elective surgery is standard guidance. Disclosure at any point is better than non-disclosure.

CBD Perioperative Interaction Summary

How to Have the Conversation With Your Surgical Team

The pre-operative assessment is the right time to disclose CBD use — typically the pre-op appointment with the surgeon and the anesthesia pre-assessment clinic. Key elements of the conversation:

• What to say: "I use CBD oil daily — approximately [dose]mg per day. I wanted to make sure you and the anesthesia team are aware because I know CBD affects CYP3A4 enzymes that metabolize some anesthetic drugs."
• What they'll likely ask: How much, how often, how recently. Have your dose and last use date ready.
• What they may recommend: Stopping CBD 1–2 weeks before the procedure. Follow this guidance — do not continue CBD in the belief that your dose is "too small to matter." The anesthesiologist is best positioned to make that assessment.
• If they are unfamiliar with CBD: Mention specifically "CBD inhibits CYP3A4 which affects the metabolism of midazolam, fentanyl, and other agents — I wanted to make sure the anesthesia team has that information." This frames the disclosure in pharmacokinetic terms familiar to the clinical team.
• Do not omit CBD from the medication list: Pre-operative medication lists should include CBD alongside prescription medications, OTC medications, and other supplements. Incomplete disclosure is a patient safety risk.

Resuming CBD After Surgery

After surgery, the primary consideration for resuming CBD is its interaction with post-operative pain medications — particularly opioids (fentanyl, oxycodone, hydrocodone — all CYP3A4 substrates) and benzodiazepines (lorazepam — UGT, lower risk; diazepam — CYP3A4, higher risk). If you are taking opioid pain medications in the immediate post-operative period, resuming CBD raises opioid levels through CYP3A4 inhibition — this requires prescriber awareness.

For patients not on opioids or CYP3A4-metabolized post-operative medications, CBD can generally be resumed once the acute surgical recovery period is complete — typically 1–2 weeks post-operatively for major surgery. CBD's anti-inflammatory (CB2) and sleep-supporting (CBN) properties may genuinely benefit the recovery period. Discuss the timeline for resuming CBD with your surgical team.

Frequently Asked Questions

Do I have to stop CBD before surgery?

Your surgeon and anesthesiologist will make that determination based on your specific procedure, health status, and other medications. Current anesthesiology guidance generally recommends stopping CBD 1–2 weeks before elective surgery to allow CYP3A4 activity to normalize. For minor procedures under local anesthesia, a shorter cessation period may be acceptable — your proceduralist will advise. What is non-negotiable is disclosure — your surgical team needs to know you use CBD to make the safest decisions about your anesthetic management.

What happens if I don't tell my surgeon I use CBD?

Non-disclosure creates patient safety risk. If CBD's CYP3A4 inhibition is not accounted for, anesthetic agents may have prolonged or intensified effects — potentially extending recovery time, requiring more intensive monitoring, or in worst-case scenarios contributing to respiratory depression in combination with other CNS depressants. Anesthesiologists are trained to manage these risks — but only when they have complete information. Disclosure is always the safer choice.

Can CBD cause excessive bleeding during surgery?

CBD's antiplatelet effect at supplement doses is mild and reversible — considerably weaker than aspirin's antiplatelet mechanism. For most elective procedures in patients with normal coagulation and not on anticoagulants, CBD at 15–25mg/day is unlikely to cause clinically significant bleeding. The bleeding concern becomes more relevant in combination with anticoagulant medications, for high-bleeding-risk procedures, or in patients with coagulation disorders. Stopping CBD 1–2 weeks before surgery eliminates this consideration entirely — the reversible antiplatelet effect resolves with clearance.

Does CBD affect local anesthesia?

CBD does not appear to significantly interact with local anesthetics (lidocaine, bupivacaine) at supplement doses. Local anesthetics are sodium channel blockers that act at the injection site; they are not primarily CYP3A4-metabolized and do not depend on the systemic pharmacokinetics that CBD affects. CBD's main interactions are with general anesthetic agents (particularly benzodiazepines, opioids, and some IV agents) rather than local anesthetics. Procedures under local anesthesia only carry lower CBD interaction risk than general anesthesia.

When can I resume CBD after surgery?

Discuss with your surgical team — the timing depends on your specific procedure and post-operative medications. If you are on opioid pain medications after surgery, resuming CBD raises opioid levels through CYP3A4 inhibition, which requires prescriber awareness. For patients not on CYP3A4-metabolized post-operative medications, CBD can generally be considered once the acute recovery period is complete (typically 1–2 weeks for major surgery). CBD's anti-inflammatory and sleep properties may support the recovery period — discuss the timeline with your surgical team.

Does CBD interact with propofol?

Propofol is the most commonly used IV induction agent in general anesthesia. Its primary metabolism is through glucuronidation (UGT enzymes) and CYP2B6 — CBD does not significantly inhibit either of these pathways. The CBD-propofol pharmacokinetic interaction is therefore low. CBD's more significant anesthetic interactions are with opioids (fentanyl, alfentanil, sufentanil — CYP3A4) and benzodiazepines (midazolam — CYP3A4). This does not mean propofol can be excluded from the disclosure conversation — it means the risk profile is lower for propofol specifically than for opioid analgesics and benzodiazepines used perioperatively.

The Bottom Line

CBD's interactions with surgical anesthesia — CYP3A4 inhibition affecting opioid and benzodiazepine metabolism, mild antiplatelet activity, and cardiovascular vasodilation — are real and clinically relevant, though not catastrophic at supplement doses with proper management. The management is straightforward: disclose CBD use to your complete surgical team, stop CBD 1–2 weeks before elective surgery as your anesthesiologist advises, and discuss post-operative resumption timing in the context of your pain management regimen. CBD is not a reason to avoid surgery — it is a reason to have a complete, honest conversation with the people responsible for your surgical safety.

PureCraft CBD Oil — resume post-surgery when cleared by your surgical team. Zero THC, batch-tested COA. Browse all PureCraft CBD products.

Medical Disclaimer | Always disclose CBD use to your complete surgical team. Follow your surgeon's and anesthesiologist's specific guidance on CBD cessation timing — do not rely solely on general guidelines. PureCraft CBD products are not intended to diagnose, treat, cure, or prevent any disease.